Sabine Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences shared a post on X, about a paper by Ingmar Wolff et al. published in Prostate Cancer and Prostatic Diseases:

“Rethinking Prostate Biopsy:

A systematic review (23 studies, 12,324 patients) shows that antibiotic prophylaxis can be omitted in transperineal biopsy with or without elevating infectious risks.”

“Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis—a systematic review including meta-analysis of all comparative studies”

Authors: Ingmar Wolff, Markus Büchner, Katharina Hauner, Florian Wagenlehner, Martin Burchardt, Marianne Abele-Horn, Bernd Wullich, Christian Gilfrich, Adrian Pilatz, Matthias May.

Sabine Brookman-May: Rethinking Prostate Biopsy

More posts featuring Sabine Brookman-May.

Sabine D. Brookman-May is the Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences. Previously, she was the Vice President of Bladder Cancer Development, Research and Development at Janssen Pharmaceutical Companies of Johnson & Johnson. She also serves as a professor of Urology at Ludwig Maximilian University of Munich, specializing in Urology, Oncology, and Sports and Exercise Medicine.